Cargando…
Efficacy of single-dose oral secnidazole for the treatment of trichomoniasis in women co-infected with trichomoniasis and bacterial vaginosis: a post hoc subgroup analysis of phase 3 clinical trial data
OBJECTIVES: Bacterial vaginosis (BV) and trichomoniasis are the most common causes of vaginitis. Both infections are associated with increased risk of acquisition and transmission of HIV and other sexually transmitted infections as well as adverse reproductive health outcomes. Co-infection is common...
Autores principales: | Muzny, Christina A, Van Gerwen, Olivia T, Kaufman, Gregory, Chavoustie, Steven |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10407359/ https://www.ncbi.nlm.nih.gov/pubmed/37550019 http://dx.doi.org/10.1136/bmjopen-2023-072071 |
Ejemplares similares
-
Efficacy and Safety of Single Oral Dosing of Secnidazole for Trichomoniasis in Women: Results of a Phase 3, Randomized, Double-Blind, Placebo-Controlled, Delayed-Treatment Study
por: Muzny, Christina A, et al.
Publicado: (2021) -
Successful Treatment of Persistent 5-Nitroimidazole–Resistant Trichomoniasis With an Extended Course of Oral Secnidazole Plus Intravaginal Boric Acid
por: McNeil, Candice J., et al.
Publicado: (2023) -
Bacterial Vaginosis and Trichomoniasis: Epidemiology and Management of Recurrent Disease
por: Soper, David E.
Publicado: (1995) -
Trichomoniasis: An update
por: Preethi, V, et al.
Publicado: (2011) -
Vaginal trichomoniasis
por: Cenkowski, Monica, et al.
Publicado: (2022)